Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Renal Cell 13Neoplasm Metastasis 12Prostatic Neoplasms 9Neoplasms 7Glioblastoma 7Kidney Neoplasms 6Brain Neoplasms 6Sarcoma 5Carcinoma, Hepatocellular 5Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Glioma 4Endometrial Neoplasms 4Colorectal Neoplasms 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Advanced Cancer 4Uterine Cervical Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Oligodendroglioma 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Liver Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2

Interventions

temsirolimus 2liposomal doxorubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Resistant Solid Malignancies × temsirolimus × Clear all
NCT00703625 2017-03-07

Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies

Washington University School of Medicine

Phase 1 Completed
26 enrolled

Resistant Solid Malignancies

NCT00703170 2013-05-24

Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

Washington University School of Medicine

Phase 1 Completed
28 enrolled

Resistant Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡